Evaluation of efficacy of Peganum harmala extract on patients with head lice
- Conditions
- Head lice.Pediculosis due to Pediculus humanus capitisB85.0
- Registration Number
- IRCT20160306026938N12
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Conformity with head lice diagnostic criteria
Age range between 18 and 65 years
Signing informed consent
Being in healthy condition
Not using local or systemic anti-lice products during the recent infection
Local or systemic anti-lice treatment or use of hair dye during or before the study period
Having serious diseases or extensive wounds, especially in the scalp area (such as impetigo or eczema), chronic scalp disorders (such as psoriasis, chronic dermatosis) and secondary scalp infection
known allergy to any of the components of the product
Treatment with antibiotics (cotrimoxazole, trimethoprim, tetracycline) or anthelmintics (such as ivermectin, levamisole, albendazole) in the last 1 month or other local or systemic drugs that may lead to errors in the test
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ice levels. Timepoint: Before the initiation of intervention and the day after the last application of formulation. Method of measurement: Scoring the patients' symptoms based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement).
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: Before the start of the intervention and one day after the last use of the formulation. Method of measurement: Completion of a 30-question questionnaire on the quality of life of head lice patients by the patient.